Article info
PDFExtended reports
Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
- Correspondence to:
T Jonsdottir, MD
Department of Rheumatology, Karolinska University Hospital, 171 76 Stockholm, Sweden; thorunn.jonsdottirkus.se
Citation
Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
Publication history
- Accepted February 16, 2004
- First published April 5, 2004.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Annals of the Rheumatic Diseases